May 19, 2016
The U.S. Food and Drug Administration (FDA) announced the recall of venlafaxine 75 mg tablets.
What prompted the Class III recall? A labeling mix-up. The medication was manufactured by Teva and repackaged by Bryant Ranch Prepack, who received the extended-release tablets, but they then labeled them as immediate-release tablets, according to the FDA’s Enforcement Report.
The impacted lot is #94983, with an expiration of October 2017. The products were distributed nationwide.
1. U.S. Food and Drug Administration. Enforcement Report – Week of May 11, 2016. www.fda.gov. Accessed May 12, 2016.